Looking to publish in Infectious Diseases and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowInfectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to high-quality clinical, observational, real-world, and health outcomes research on infectious disease therapies and interventions, including vaccines and devices. It also welcomes research on diagnostics, pharmacoeconomics, public health, epidemiology, quality of life, patient care, management, and education, and publishes original research, reviews, case reports, trial protocols, short communications, commentaries, editorials, and letters.
Looking to publish in Infectious Diseases and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Infectious Diseases and Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Brief Report
Editorial
Letter to the Editor
Guideline
Recent Publications
Response Letter to ‘Letter to the Editor Regarding Complementary Strategy of Maternal Immunization and Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Among Italian Infants: A Cost-Effectiveness Assessment’
Barbara Polistena, Fabio Midulla, Giovanni Sotgiu, Daniela d’Angela, Roberto Di Virgilio, Federico Spandonaro
Letter to the Editor Regarding “Complementary Strategy of Maternal Immunization and Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Among Italian Infants: A Cost-Effectiveness Assessment”
Claudio Costantino, Gabriele Giorgianni, Roberto Furnari, Vincenzo Di Gaetano, Fabio Massimo Contarino
Disparities in Adult Influenza Vaccination in the United States: Analysis of 2023 BRFSS Data
Christian Smolen, Joseph Fava, Paul E. Kilgore
Comparison of the Hospital Burden Associated with Respiratory Syncytial Virus and Human Metapneumovirus Across All Age Groups in Scotland: A Retrospective Analysis
Durga Kulkarni, Richard Osei-Yeboah, You Li, Kate Templeton, Harish Nair
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study
Maria Vittoria Cossu, Davide Moschese, Maddalena Matone, Letizia Oreni, Giorgia Carrozzo, Andrea Poloni, Giacomo Pozza, Laura Albini, Gabriele Forcina, Cristina Gervasoni, Agostino Riva, Andrea Giacomelli, Andrea Gori
Frequently asked questions
How long does it take to publish?
2-week peer review; 3-4 weeks from acceptance to online publication; submission to first decision median is 1 day.
Reformat to Infectious Diseases and Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is required to highlight publication deadlines, trial registration details, open access choice for Advances in Therapy, and any relevant submission information.
Reformat to Infectious Diseases and Therapy using Livewrite PremiumWhat are the publication costs?
Mandatory Rapid Service Fee of €5950/$7675/£5120 upon acceptance; open access publication costs included.
Reformat to Infectious Diseases and Therapy using Livewrite Premium